BUY Alivus Life Sciences Limited — ICICI Securities
Alivus Life Sciences share price target & all analyst calls
byICICI SecuritiesHorizon: NA (inferred 1 year)23 Jan 2026via Institutional / Brokerage Research
Entry₹883.5Inferred
Stop lossNot given
Exit₹1,1902 Jul 2026, 12:07 pm
Follow ICICI Securities for new calls(67% target hit, 1027 closed calls)Get alertsWatch ALIVUS for new buy/sell callsGet alertsSee 276 active Long-term picks this week
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 supporting0 opposing
Supports the BUY call (3)
Nothing found in this tip’s window yet.
Neutral / worth noting (0)
Nothing found in this tip’s window yet.
Weighs against the BUY call (0)
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Alivus Life Sciences
- BUY — Siddharth Rai Mangala9 Sept 2026 · ~2 weeks · target ₹1,530 · SL hit
- BUY — Shrikant Chouhan, Kotak Securities30 Jun 2026 · ~3 months · target ₹1,315 · Target hit
- BUY — ICICI Securities15 May 2026 · ~1 year · target ₹1,235 · Target hit
- BUY — ICICI Securities7 Nov 2025 · ~1 year · target ₹1,180 · Target hit
- BUY — ICICI Securities26 Aug 2024 · ~1 year · target ₹1,295 · Target hit
More from ICICI Securities
- BUY CIE Automotive India23 Oct 2026 · ~1 year · target ₹475 · Active
- BUY SAGILITY23 Oct 2026 · ~1 year · target ₹55 · Active
- BUY CREDITACCESS GRAMEEN23 Oct 2026 · ~1 year · target ₹1,500 · Active
- BUY Havells India23 Oct 2026 · ~1 year · target ₹1,500 · Active
- BUY Balkrishna Industries22 Oct 2026 · ~1 year · target ₹2,675 · Active

